시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 흡입 캡슐 시장 규모, 점유율, 동향 분석 : 유형별, 용도별, 지역별 전망 및 예측(2024-2031년)
Global Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Regional Outlook and Forecast, 2024 - 2031
상품코드 : 1472510
리서치사 : KBV Research
발행일 : 2024년 04월
페이지 정보 : 영문 182 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,197,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,237,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,732,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 흡입 캡슐 시장 규모는 2031년까지 14억 달러에 달할 것으로 예상되며, 예측 기간 동안 CAGR 5.9%로 성장할 것으로 예상됩니다.

또한, 의료 인프라가 개선되고 의료 서비스에 대한 접근성이 높아짐에 따라 호흡기 질환에 대한 효과적이고 편리한 치료 옵션에 대한 수요가 증가함에 따라 흡입 캡슐에 대한 수요가 증가하고 있습니다. 예를 들어, 헬스케어 산업이 빠르게 성장하고 있는 중국, 인도와 같은 국가에서는 대기오염, 흡연 등의 요인으로 인해 호흡기 질환의 유병률이 크게 증가하고 있습니다. 따라서 전 세계적으로 헬스케어 산업이 크게 확대되면서 시장 성장을 촉진할 수 있는 환경이 조성되고 있습니다.

그러나 흡입 캡슐은 약물을 폐에 직접 주입하지만 약물의 일부가 혈류로 들어가 전신 부작용을 일으킬 수 있습니다. 이러한 부작용에는 심혈관에 미치는 영향, 혈압 변화, 대사 매개 변수 변화 등이 포함됩니다. 특히 장기 사용이나 고용량의 경우 환자와 의료 전문가는 흡입 요법과 관련된 전신 부작용의 가능성에 대해 우려할 수 있습니다. 따라서 이러한 요인들은 시장 성장을 저해할 수 있습니다.

또한, COVID-19 팬데믹은 수요 역학, 공급망, 의료 서비스 제공 방식을 재편하고 있습니다. 팬데믹 기간 동안 호흡기 건강에 대한 관심이 높아지고 천식이나 COPD와 같은 호흡기 질환을 관리하려는 환자가 증가함에 따라 흡입 캡슐로 투여되는 약물에 대한 수요가 증가했습니다. 따라서 전염병은 전반적으로 시장에 긍정적인 영향을 미쳤습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 흡입 캡슐 시장에서 전개되고 있는 최근의 전략

제5장 세계의 흡입 캡슐 시장 : 유형별

제6장 세계의 흡입 캡슐 시장 : 용도별

제7장 세계의 흡입 캡슐 시장 : 지역별

제8장 기업 개요

제9장 흡입 캡슐 시장 성공 필수 조건

ksm
영문 목차

영문목차

The Global Inhalation Capsules Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.

Several factors contribute to the high prevalence of asthma in the U.S., including air pollution, allergens, tobacco smoke, and obesity. Urban areas, particularly in the Northeast and Midwest, have higher asthma rates due to higher air pollution and allergens. Consequently, the North America region generated USD 312.7 million revenue of the market in 2023. Moreover, the region has high healthcare spending, allowing patients better access to advanced treatment options, including inhalation capsules.

Technological advancements have resulted in the development of inhalation devices that are easier to use and more intuitive for patients. Features such as one-click mechanisms, ergonomic designs, and simplified instructions make inhalation devices more user-friendly, improving patient adherence and satisfaction. Advanced inhalation devices incorporate mechanisms to ensure precise and consistent medication dosing. Therefore, as these technological advancements evolve, the market is expected to expand further.

Additionally, as healthcare infrastructure improves and access to medical services increases, a growing demand for effective and convenient treatment options for respiratory diseases drives the demand for inhalation capsules. For example, in countries like China and India, where the healthcare industry is rapidly expanding, there is a significant increase in the prevalence of respiratory diseases due to factors such as air pollution and smoking. Hence, the substantial expansion of the healthcare industry globally has created a conducive environment for the growth of the market.

However, Inhalation capsules deliver medication directly to the lungs, but some amount of the drug may enter the bloodstream and cause systemic side effects. These side effects can include cardiovascular effects, changes in blood pressure, or alterations in metabolic parameters. Particularly with prolonged use or high doses, patients and medical professionals may be concerned about the potential for systemic adverse effects associated with inhalation therapies. Hence, these factors may hamper the market's growth.

Furthermore, the COVID-19 pandemic reshaping demand dynamics, supply chains, and healthcare delivery methods. With the heightened focus on respiratory health during the pandemic, there was an increased demand for medications delivered via inhalation capsules, driven by patients seeking to manage respiratory conditions such as asthma and COPD. Thus, the pandemic had an overall positive impact on the market.

By Type Analysis

Based on type, the market is characterized by gelatin capsules and hypromellose capsules. In 2023, the hypromellose capsules segment recorded a 38.2% revenue share in the market. Hypromellose capsules, also known as hydroxypropyl methylcellulose (HPMC) capsules, are gaining within the market. HPMC capsules offer several key benefits that make them well-suited for inhalation therapy. This versatility enables pharmaceutical companies to develop inhalation capsules containing various active pharmaceutical ingredients, catering to the specific needs of patients with different respiratory conditions.

By Application Analysis

On the basis of application, the market is classified into asthma treatment, COPD management, and others. The asthma treatment segment procured 48.5% revenue share in the market in 2023. Asthma treatment within the market encompasses a wide range of medications and delivery devices tailored to manage the symptoms and underlying inflammation associated with this chronic respiratory condition. Inhalation therapy is considered the cornerstone of asthma management because it delivers medications directly to the lungs, resulting in rapid onset of action, targeted treatment, and reduced systemic side effects.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe region held a 29.3% revenue share in the market in 2023. Europe is a leader in healthcare technology, leading to the development of advanced inhalation devices and formulations that drive market growth. Patients and healthcare professionals alike are well-informed regarding the advantages of inhalation therapy, which is propelling market expansion. Moreover, Europe has a favorable regulatory environment for developing and commercializing inhalation capsules, encouraging market growth.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Inhalation Capsules Market Report Segmentation

By Type

By Application

By Geography

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5.Global Inhalation Capsules Market by Type

Chapter 6.Global Inhalation Capsules Market by Application

Chapter 7.Global Inhalation Capsules Market by Region

Chapter 8.Company Profiles

Chapter 9.Winning Imperatives of Inhalation Capsules Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기